Oculis Holding AG

OCS Stock Healthcare Biotechnology
$7.29
-0.11 (-1.49%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-27.0%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Largest decline max drawdown, since Aug 2026
-47.2%

Own OCS?

See how OCS contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.